Official Title
Developement and Evaluation of Serological Assays for COVID-19
Brief Summary

The primary objective of the study aims to evaluate serological assays of virus Covid-19.

Detailed Description

This is a retrospective monocentric study, which will include the patients who have
hospitalized in Ambroise Paré Hospital and have sampling sent to the Laboratory of
Microbiology of the hospital between the 15 March 2020 and 30 september 2020.

Unknown status
COVID-19
Eligibility Criteria

Inclusion Criteria:

- Patient ≥ 18 years;

- Have molecular diagnosis of positive or negative result in Covid-19 virus by the
Laboratory of Microbiology in Ambroise Paré Hospital;

- Have diagnosed of a viral infection in respiratory.

Exclusion Criteria:

- Patient refusal.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

Laboratory of microbiology of hospital hygiene, Ambroise Paré Hospital, APHP
Boulogne-Billancourt, France

Contacts

Marie-Anne RAMEIX-WELTI, MD, PhD
+33 (0)6 65 13 64 34
marie-anne.welti@aphp.fr

Marie-Anne RAMEIX-WELTI, MD, PhD, Principal Investigator
Laboratoire de Microbiologie Hygiène hospitalière, Hôpital Ambroise paré, APHP

Assistance Publique - Hôpitaux de Paris
NCT Number
Keywords
Covid-19
serological assay
MeSH Terms
COVID-19